Search Results for keywords:"Thomas Morris"

LCM Healthcare Fund I, L.P., located in Dallas, Texas, is a federal licensee under the Small Business Investment Act seeking an exemption from the U.S. Small Business Administration (SBA). The exemption is requested for a proposed equity financing deal with Northwest Surgical Development Company, Inc., which is considered a conflict of interest as it does not meet specific terms and conditions required by SBA regulations. The SBA is asking for public comments on this transaction within fifteen days of the notice's publication. Thomas Morris from the SBA is in charge of this matter.

The United States Small Business Administration (SBA) has declared the licenses of Plexus Fund III, L.P. and Plexus Fund QP III, L.P. to operate as small business investment companies to be null and void. This decision was made under the authority of the Small Business Investment Act of 1958 and relevant federal regulations. Thomas Morris, the Director of Patient Capital Investments, is the official who announced this action on behalf of the SBA.

The United States Small Business Administration has revoked the license of the Stonehenge Opportunity Fund III-B, L.P. as a small business investment company. This action was taken under the authority of Section 309 of the Small Business Investment Act of 1958 and 13 CFR 107.1900. As a result, the license held by Stonehenge Opportunity Fund III-B, L.P. is now null and void. The decision was announced by Thomas Morris, Director of Patient Capital Investments.

The United States Small Business Administration (SBA) announced that it has canceled the license for LongueVue Capital Partners II, LP to operate as a small business investment company. This decision was made under the authority granted by the Small Business Investment Act of 1958 and relevant federal regulations. Thomas Morris, the Director of Patient Capital Investments at the SBA, issued this notice.